- Title
- Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats
- Creator
- Nadhanan, Rethi Raghu; Skinner, Jayne; Chung, Rosa; Su, Yu-Wen; Howe, Peter R.; Xian, Cory J.
- Relation
- NHMRC
- Relation
- PLoS One Vol. 8, Issue 8
- Publisher Link
- http://dx.doi.org/10.1371/journal.pone.0071592
- Publisher
- Public Library of Science
- Resource Type
- journal article
- Date
- 2013
- Description
- Cancer chemotherapy has been shown to induce long-term skeletal side effects such as osteoporosis and fractures; however, there are no preventative treatments. This study investigated the damaging effects of anti-metabolite methotrexate (MTX) subcutaneous injections (0.75 mg/kg BW) for five days and the potential protective benefits of daily oral gavage of fish oil at 0.5 mL/100 g BW (containing 375 mg of n-3 PUFA/100 g BW), genistein (2 mg/100 g BW), or their combination in young adult rats. MTX treatment alone significantly reduced primary spongiosa height and secondary spongiosa trabecular bone volume. Bone marrow stromal cells from the treated rats showed a significant reduction in osteogenic differentiation but an increase in adipogenesis ex vivo. Consistently, stromal cells had significantly higher mRNA levels of adipogenesis-related proliferator activator activated receptor-γ (PPAR-γ) and fatty acid binding protein (FABP4). MTX significantly increased the numbers of bone-resorbing osteoclasts and marrow osteoclast precursor cell pool while significantly enhancing the mRNA expression of receptor activator for nuclear factor kappa B ligand (RANKL), the RANKL/osteoprotegerin (OPG) ratio, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the bone. Supplementary treatment with fish oil and/or genistein significantly preserved trabecular bone volume and osteogenesis but suppressed MTX-induced adipogenesis and increases in osteoclast numbers and pro-osteoclastogenic cytokine expression. Thus, Fish oil and/or genistein supplementation during MTX treatment enabled not only preservation of osteogenic differentiation, osteoblast number and bone volume, but also prevention of MTX treatment-induced increases in bone marrow adiposity, osteoclastogenic cytokine expression and osteoclast formation, and thus bone loss.
- Subject
- chemotherapy; osteoporosis; fish oil; genistein; rats; methotrexate
- Identifier
- http://hdl.handle.net/1959.13/1048562
- Identifier
- uon:14924
- Identifier
- ISSN:1932-6203
- Language
- eng
- Full Text
- Reviewed
- Hits: 5657
- Visitors: 5859
- Downloads: 264
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT01 | Publisher version (open access) | 4 MB | Adobe Acrobat PDF | View Details Download |